NEW YORK (GenomeWeb) — Premaitha Health reported a 24 percent revenue increase for its fiscal year 2016/2017 today.

For the year ended March 31, the Manchester, UK-based molecular diagnostics company, which focuses on noninvasive prenatal testing, had more than £3.1 million ($4 million) in revenue, up from £2.5 million during the previous fiscal year.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.